S E Purdon

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. pmc Olfactory identification and Stroop interference converge in schizophrenia
    S E Purdon
    Department of Neuropsychology, Alberta Hospital Edmonton
    J Psychiatry Neurosci 23:163-71. 1998
  2. ncbi request reprint Cognitive improvement in schizophrenia with novel antipsychotic medications
    S E Purdon
    Neuropsychology, Alberta Hospital Edmonton, Alb, Canada
    Schizophr Res 35:S51-60. 1999
  3. ncbi request reprint Neuropsychological change in schizophrenia after 6 weeks of clozapine
    S E Purdon
    Department of Psychiatry, University of Alberta, Alberta, Edmonton, Canada
    Schizophr Res 48:57-67. 2001
  4. ncbi request reprint Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia
    S E Purdon
    University of Alberta and Alberta Hospital, Edmonton, Canada
    Arch Gen Psychiatry 57:249-58. 2000
  5. pmc Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
    S E Purdon
    University of Alberta, Edmonton, Alta
    J Psychiatry Neurosci 26:137-49. 2001
  6. ncbi request reprint Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
    S E Purdon
    Alberta Hospital Edmonton, Box 307, Edmonton, T5J 2J7, Alberta, Canada
    Schizophr Res 44:221-32. 2000

Detail Information

Publications6

  1. pmc Olfactory identification and Stroop interference converge in schizophrenia
    S E Purdon
    Department of Neuropsychology, Alberta Hospital Edmonton
    J Psychiatry Neurosci 23:163-71. 1998
    ..To test the discriminant validity of a model predicting a dissociation between measures of right and left frontal lobe function in people with schizophrenia...
  2. ncbi request reprint Cognitive improvement in schizophrenia with novel antipsychotic medications
    S E Purdon
    Neuropsychology, Alberta Hospital Edmonton, Alb, Canada
    Schizophr Res 35:S51-60. 1999
    ....
  3. ncbi request reprint Neuropsychological change in schizophrenia after 6 weeks of clozapine
    S E Purdon
    Department of Psychiatry, University of Alberta, Alberta, Edmonton, Canada
    Schizophr Res 48:57-67. 2001
    ....
  4. ncbi request reprint Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia
    S E Purdon
    University of Alberta and Alberta Hospital, Edmonton, Canada
    Arch Gen Psychiatry 57:249-58. 2000
    ..The purpose of this investigation was to test the efficacy of novel antipsychotic medications in the treatment of cognitive impairment in early phase schizophrenia...
  5. pmc Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol
    S E Purdon
    University of Alberta, Edmonton, Alta
    J Psychiatry Neurosci 26:137-49. 2001
    ..To assess the efficacy of quetiapine, a recently introduced second generation antipsychotic medication, in reducing cognitive impairment in patients with schizophrenia...
  6. ncbi request reprint Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
    S E Purdon
    Alberta Hospital Edmonton, Box 307, Edmonton, T5J 2J7, Alberta, Canada
    Schizophr Res 44:221-32. 2000
    ..Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment...